Contribution of noncovalent recognition and reactivity to the optimization of covalent inhibitors: a case study on KRas G12C
*Correspondence: Hong-Tao Zhang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Tirzepatide, a dual-agonist peptide, has shown significant results with a 22.5% weight loss over 72 weeks at a 15 mg dose (Jastreboff et al., NEJM), making it one of the most effective therapies for obesity
Elkalla N, Elhamammsy MH, Bedair NI, Elazazy O, El Kholy AA
mexicana triggered a rapid accumulation of eosinophilic granulocytes (SSC high CD11b + SiglecF + cells) at the site of inoculation, detectable as early as day 6 post infection (p.i.) (Fig